Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on GLP 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel alkaline hydrolysis method for Semaglutide backbone fragments. High purity, simplified steps, and cost-effective manufacturing for GLP-1 analog intermediates.
Patent CN109627317A details a solid-liquid hybrid fragment condensation method for Semaglutide, offering high purity and reduced waste for scalable supply chains.
Patent CN119638592A discloses a novel route for semaglutide side chain. Achieve high purity and reduced emulsification risks for scalable GLP-1 manufacturing.
Advanced fragment condensation method for Semaglutide production. Reduces costs and waste while ensuring high purity for reliable pharmaceutical intermediate supply chains.
Patent CN117510377A details a novel 4-step synthesis for high-purity Fmoc-Glu-OtBu. This method ensures cost reduction and supply chain reliability for peptide manufacturing.